[go: up one dir, main page]

DE621862C - Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes - Google Patents

Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes

Info

Publication number
DE621862C
DE621862C DESCH98196D DESC098196D DE621862C DE 621862 C DE621862 C DE 621862C DE SCH98196 D DESCH98196 D DE SCH98196D DE SC098196 D DESC098196 D DE SC098196D DE 621862 C DE621862 C DE 621862C
Authority
DE
Germany
Prior art keywords
nucleus
fluorinated aryl
condensation products
aryl aldehydes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DESCH98196D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUENTHER SCHIEMANN DR
WILHELM ROSELIUS DR ING
WOLFGANG WINKELMUELLER DR ING
Original Assignee
GUENTHER SCHIEMANN DR
WILHELM ROSELIUS DR ING
WOLFGANG WINKELMUELLER DR ING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUENTHER SCHIEMANN DR, WILHELM ROSELIUS DR ING, WOLFGANG WINKELMUELLER DR ING filed Critical GUENTHER SCHIEMANN DR
Priority to DESCH98196D priority Critical patent/DE621862C/en
Application granted granted Critical
Publication of DE621862C publication Critical patent/DE621862C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Verfahren zur Darstellung von Kondensationsprodukten kernfluorierter Arylaldehyde Während bei der Einwirkung von Fluor selbst oder anorganischen Fluoriden auf Mensch und Tier die Giftwirkung überwiegt, wurde festgestellt, daß kernfluorierte Aminosäuren, z. B. Fluorphenylalanin, Fluortyrosin und ihre Abkömmlinge sowie ß-Fluorpheny 1-äthylamine, bestimmte, wertvolle physiologische Wirkungen ausüben. Das Verhalten der angeführten, bisher unbekannten Stoffklassen ist durch ihren Gehalt an Fluor bedingt.Process for the preparation of condensation products of nuclear fluorinated Arylaldehydes While under the action of fluorine itself or inorganic fluorides the poisonous effect predominates on humans and animals, it was found that nuclear fluorinated Amino acids, e.g. B. fluorophenylalanine, fluorotyrosine and their derivatives and ß-fluoropheny 1-ethylamine, exert certain valuable physiological effects. Behaviour of the previously unknown classes of substances is due to their fluorine content conditional.

Die bisher bekannten Verfahren zur Einführung von Fluor in Arylkerne sind auf Umsetzungen von Diazoniumverbindungen gegründet. Sie sind für eine Fluorierung der zugrunde liegenden Grundstoffe oben beschriebener kernfluorierter Verbindungsklassen unbrauchbar. Obwohl ferner manche Reaktionen mit aromatischen Fluorverbindungen sich so durchführen lassen, als wäre kein Fluor im Molekül vorhanden, sind doch Fälle bekannt, in denen sich fluorierte Verbindungen grundlegend anders verhalten als die entsprechenden fluorfreien oder durch andere Halogene substituierten Verbindungen (vgl. H. H. Hodgson und J. Nixon, Journ. of the chemical Society 1930, S. 1o85). Danach war nicht vorauszusehen, ob sich kernfluorierte Arylaldehyde unter Erhalt des Fluors am Kern in gleicher Weise wie die nichtfluorierten Benzaldehyde umsetzen würden.The previously known processes for introducing fluorine into aryl nuclei are based on reactions of diazonium compounds. They cannot be used for fluorination of the basic materials of the nuclear fluorinated compound classes described above. Furthermore, although some reactions with aromatic fluorine compounds can be carried out as if there were no fluorine in the molecule, cases are known in which fluorinated compounds behave fundamentally different from the corresponding fluorine-free compounds or compounds substituted by other halogens (cf.HH Hodgson and J. . Nixon, Journ. Of the chemical Society 1930, p. 1085). According to this, it could not be foreseen whether nuclear fluorinated aryl aldehydes would react in the same way as the non-fluorinated benzaldehydes while retaining the fluorine on the core.

Es wurde nun gefunden, daß mit Fluorbenzaldehyden und ihren Substitutionsprodukten Kondensationen wie Erlenmeyers Aminosäuresynthese, Perkinsche Zimtsäuresynthese oder die Kondensation mit Malonsäure so verliefen, als wäre kein Fluor im Aldehyd vorhanden. Z. B. läßt sich Fluorbenzaldehyd mit Hippursäure, Hydantoin oder Glycinanhydrid, mit Malonsäure oder sonstigen, kondensationsfähige Methylengruppen enthaltenden Verbindungen bei Gegenwart oder Abwesenheit von Lösungsmitteln sowie gebräuchlichen Kondensationsmitteln,. wie z. B. Essigsäüreanhydrid, Pyridin, Natriumacetat, gegebenenfalls bei erhöhter Temperatur, zu fluorhaltigen Kondensationsprodukten umsetzen. Die so erhaltenen Verbindungen lassen sich nach an sich bekannten Methoden weiter ohne Verlust des Fluors umsetzen und sollen als Zwischenprodukte zur Herstellung von pharmazeutisch wirksamen fluorhaltigen Stoffen Verwendung finden. Beispiel 1 Je 1 Mol p-Fluorbenzaldehyd und Hippursäure werden mit wasserfreiem Natriumacetat innig gemischt und mit Essigsäureanhydrid auf dem Wasserbade 1@2 Stunde erwärmt. Die Menge des Essigsäureanhydrids wird so gewählt, daB_ alle feste Substanz beim Erwärmen in Lösung geht. Aus der erhaltenen klaren gelben Lösung kristallisieren beim Erkalten die gelben Nadeln des Kondensationsproduktes in sehr guter Ausbeute aus, die, aus Eisessig umkristallisiert, den F. 181,5° besitzen. Durch Kochen des so erhaltenen 2-Phenyl-4-(p-fluorbenzal)-oxazolon-(5) mit jodwasserstoffsäure und rotem Phosphor in Essigsäureanhydrid entsteht p-Fluorphenylalänin.It has now been found that with fluorobenzaldehydes and their substitution products Condensations such as Erlenmeyer's amino acid synthesis, Perkin's cinnamic acid synthesis or the condensation with malonic acid proceeded as if there were no fluorine in the aldehyde available. For example, fluorobenzaldehyde can be combined with hippuric acid, hydantoin or glycine anhydride, with malonic acid or other condensable methylene groups Compounds in the presence or absence of solvents as well as common ones Condensing agents ,. such as B. acetic anhydride, pyridine, sodium acetate, optionally at elevated temperature to convert to fluorine-containing condensation products. The so The compounds obtained can be further removed by methods known per se Implement loss of fluorine and are intended as intermediates for the production of Find pharmaceutically active fluorine-containing substances use. Example 1 each 1 mole of p-fluorobenzaldehyde and hippuric acid become intimate with anhydrous sodium acetate mixed and heated with acetic anhydride on the water bath 1 @ 2 hours. the The amount of acetic anhydride is chosen in such a way that all solid matter is heated up goes into solution. The clear yellow solution obtained crystallizes on cooling the yellow needles of the condensation product in very good yield, the, from Recrystallized glacial acetic acid, which have a temperature of 181.5 °. By boiling the so obtained 2-Phenyl-4- (p-fluorobenzal) -oxazolone- (5) with hydriodic acid and red phosphorus p-fluorophenylalanine is formed in acetic anhydride.

Beispiel e Wie in Beispiel i werden molekulare Mengen von 3-Fluor-4-äthoxybenzaldehyd und Hippursäure miteinander umgesetzt. Es entsteht bei gleichem Reaktionsverlaufe in ebenfalls sehr guter Ausbeute das Azlakton, dessen F. 167,5° beträgt. Beispiel 3 Wie in Beispiel i werden molekulare Mengen von 4-(4'-Methoxyphenoxy)-2-fluorbenzaldehyd und Hippursäure miteinander umgesetzt. Es entsteht bei gleichem Reaktionsverlauf in ebenfalls sehr guter Ausbeute ein Azlakton vom F. i55°. Beispiel 4 Je i Mol o-Fluorbenzaldehyd und Hydantoin werden mit Natriumacetat und Eisessig, dein etwas Essigsäureanhydrid zugesetzt ist, 3 Stunden im Ölbade bei 140° erwärmt: Durch Eingießen der noch heißen Reaktionsmasse in Wasser wird das Kondensationsprodukt in sehr guter Ausbeute als gelbgrauer Niederschlag vom F. 232° (aus Alkohol) erhalten. Beispiel 5 Wie in Beispiel 4 werden 2 Mol o-FluorbenZ'aldehyd und z Mol Glycinanhydrid mitleInandrer umgesetzt. Es entsteht bereits nach wenigen Minuten in guter Ausbeute 3, 6-Di-(2-fluorbenzal)-2, 5-dioxopiperazin vom Zersetzungspunkt 3100. Beispiel 6 Molekulare Mengen von m-Fluorbenzaldehyd und Malonsäure werden mit 2 Mol alkoholischem Ammoniak, mit Pyridin oder piperidinhaltigem Pyridin auf dem Wasserbade unter Rückfluß erwärmt. Eine Lösung des Niederschlages tritt dabei nicht ein, sehr bald scheiden sich Kristallnadeln der m-Fluorbenzalmalonsäure ab. Schon während des Erhitzens auf dem Wasserbade tritt teilweise Decarboxylierung ein. Nach vollständiger Umsetzung wird der Alkohol oder das Pyridin abdestilliert und, wenn nötig, der Rückstand bis zum Aufhören der Gasentwicklung im Ölbade auf 18o bis 19o° erwärmt. Das zurückbleibende Öl erstarrt beim Erkalten. Die so in guter Ausbeute und sehr rein erhaltene m-Fluorzimtsäure schmilzt bei 16o°.Example e As in Example i, there are molecular amounts of 3-fluoro-4-ethoxybenzaldehyde and hippuric acid reacted with one another. It arises with the same course of the reaction Azlactone, which has a melting point of 167.5 °, also has a very good yield. example 3 As in Example i, molecular amounts of 4- (4'-methoxyphenoxy) -2-fluorobenzaldehyde and hippuric acid reacted with one another. It arises with the same course of the reaction also in very good yield an azlactone with a temperature of 55 °. Example 4 Each i mole of o-fluorobenzaldehyde and hydantoin are made with sodium acetate and glacial acetic acid, your little acetic anhydride is added, heated for 3 hours in an oil bath at 140 °: By pouring in the still hot Reaction mass in water is called the condensation product in very good yield yellow-gray precipitate with a temperature of 232 ° (from alcohol). Example 5 As in example 4 2 moles of o-fluorobenzaldehyde and z moles of glycine anhydride are reacted with one another. After a few minutes there is a good yield of 3,6-di- (2-fluorobenzal) -2, 5-dioxopiperazine of decomposition point 3100. Example 6 Molecular amounts of m-fluorobenzaldehyde and malonic acid are mixed with 2 moles of alcoholic ammonia, with pyridine or with piperidine Pyridine refluxed on the water bath. A solution of the precipitate does not occur, very soon crystal needles of m-fluorobenzalmalonic acid separate away. Partial decarboxylation already occurs during heating on the water bath a. When the reaction is complete, the alcohol or the pyridine is distilled off and, if necessary, the residue in the oil bath until gas evolution ceases Heated between 18o and 19o °. The remaining oil solidifies when it cools. The so in good Yield and m-fluorocinnamic acid obtained in very pure form melts at 160 °.

Claims (1)

PATENTANSPRUCH: Verfahren zur Darstellung von kondensationsprodukten kernfluorierter Arylaldehyde, dadurch gekennzeichnet, daß man kernfluorierte Arylaldeliyde mit Stoffen, die eine kondensationsfähige Methylengruppe enthalten oder eine solche zu liefern vermögen, in An- oder Abwesenheit von Lösungsmitteln sowie der gebräuchlichen Kondensationsmittel, gegebenenfalls bei erhöhter Temperatur, aufeinander einwirken läßt.PATENT CLAIM: Process for the representation of condensation products Nuclear fluorinated aryl aldehydes, characterized in that nucleus fluorinated aryl aldehydes with substances that contain or contain a condensable methylene group able to deliver, in the presence or absence of solvents as well as the usual Condensation agents, if necessary at elevated temperature, act on one another leaves.
DESCH98196D 1932-07-01 1932-07-01 Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes Expired DE621862C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DESCH98196D DE621862C (en) 1932-07-01 1932-07-01 Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH98196D DE621862C (en) 1932-07-01 1932-07-01 Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes

Publications (1)

Publication Number Publication Date
DE621862C true DE621862C (en) 1935-11-14

Family

ID=7446324

Family Applications (1)

Application Number Title Priority Date Filing Date
DESCH98196D Expired DE621862C (en) 1932-07-01 1932-07-01 Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes

Country Status (1)

Country Link
DE (1) DE621862C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021830A1 (en) * 1994-02-14 1995-08-17 Xenova Limited Pharmaceutical piperazin compounds
WO1995021829A1 (en) * 1994-02-14 1995-08-17 Xenova Limited Pharmaceutical piperazine compounds
WO1995021832A1 (en) * 1994-02-14 1995-08-17 Xenova Limited Pharmaceutical piperazine compounds
US5700804A (en) * 1992-08-14 1997-12-23 Xenova Limited Pharmaceutical compounds
US5891877A (en) * 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700804A (en) * 1992-08-14 1997-12-23 Xenova Limited Pharmaceutical compounds
WO1995021830A1 (en) * 1994-02-14 1995-08-17 Xenova Limited Pharmaceutical piperazin compounds
WO1995021829A1 (en) * 1994-02-14 1995-08-17 Xenova Limited Pharmaceutical piperazine compounds
WO1995021832A1 (en) * 1994-02-14 1995-08-17 Xenova Limited Pharmaceutical piperazine compounds
JPH09508639A (en) * 1994-02-14 1997-09-02 ゼノバ リミテッド Pharmaceutical piperazine compound
US5852018A (en) * 1994-02-14 1998-12-22 Xenova Limited Pharmaceutical piperazine compounds
US5902812A (en) * 1994-02-14 1999-05-11 Xenova Limited Pharmaceutical piperazine compounds
US5891877A (en) * 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
DE2723937A1 (en) 4-AMINO-4-ARYLCYCLOHEXANONE COMPOUNDS, METHODS FOR THEIR MANUFACTURING, INTERMEDIATES USED IN THEIR MANUFACTURING, AND MEDICINAL PRODUCTS
DE621862C (en) Process for the preparation of condensation products of nucleus fluorinated aryl aldehydes
DE2237592C2 (en) 6- (o-Chlorophenyl) -8-chloro-4H-imidazo- [1,2-a] [1,4] -benzodiazepines and processes for their preparation
DE2717001A1 (en) MEDICINAL PRODUCTS WITH ANTITHROMBOTIC EFFECT
DE2853175A1 (en) PROCESS FOR THE MANUFACTURING OF ALKANDIOL DIAMINOBENZOATES
EP0000013A1 (en) 4-Phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing them and process for preparation of these compositions
DE651351C (en) Process for the production of polynuclear, partially hydrogenated ring systems
DE539178C (en) Process for the preparation of hydrogenated amides of nicotinic acid
DE1470422C (en) l-Cyclopropylmethyl-S-phenyl-? chloro-1,2-dihydro-3 H-1,4-benzodiazepinone- (2)
DE1620536C (en) Process for the production of alpha pyrrolidinoketones and their salts
DE1518832C3 (en)
DE704761C (en) Process for the preparation of pyridine compounds
DE668628C (en) Process for the preparation of alkyl and aralkyl compounds of 3,4-cyclotetramethylene-1-aryl-5-pyrazolones
DE966534C (en) Process for the preparation of basic substituted pyridine compounds
DE587428C (en) Process for the preparation of 1, 5, 5- and 1, 3, 5, 5-substituted barbituric acids
DD211346A1 (en) PROCESS FOR PREPARING 3-BENZYL-4-P-METHOXYPHENYL-1,2,4-TRIAZOLIN-5-ON
DE663543C (en) Process for the production of Abkoemmlingen the pyrazine monocarboxylic acid
AT247329B (en) Process for the production of new, basic ketones
DE1445466C (en) Trisubstituted Delta hoch 2 -Pyrazolin-5-ones, their metal salts and a process for their preparation
DE1445845C (en) 5-phenyl-6,7-benzomorphane
DE533038C (en) Process for the preparation of phenylaethenyl-p-diaethoxydiphenylamidine
DE2035494C (en) A new derivative of 2H indazolone 3, its hydrobromide and drugs made from these compounds
DE530496C (en) Process for the preparation of basic substituted indoles and tetrahydrocarbazoles
DE533692C (en) Process for the preparation of clusters of 4,5-oxidophenanthrene
DE591937C (en) Process for the preparation of arsenic compounds of the quinoline series